蝶窦及颅内硬膜下沟通性脑膜瘤一例

2018-11-15 罗乐凯 任翠萍 张勇 临床放射学杂志

患者男,54岁。3年前无明显诱因出现双眼肿胀,反复发作,右眼较重。2周前无明显诱因出现右颌面部麻木,偶伴头痛。于当地医院行CT检查,诊断结果:右侧前颅窝底恶性占位病变,累及右侧蝶窦、右侧颞肌及前颅窝多发骨质破坏。门诊以“右蝶窦前颅底肿物并周围骨质破坏”收入院。患病以来,患者神志清,易疲劳,食欲正常,睡眠正常,大小便正常,体重无减轻。

患者男,54岁。3年前无明显诱因出现双眼肿胀,反复发作,右眼较重。2周前无明显诱因出现右颌面部麻木,偶伴头痛。于当地医院行CT检查,诊断结果:右侧前颅窝底恶性占位病变,累及右侧蝶窦、右侧颞肌及前颅窝多发骨质破坏。门诊以“右蝶窦前颅底肿物并周围骨质破坏”收入院。患病以来,患者神志清,易疲劳,食欲正常,睡眠正常,大小便正常,体重无减轻。
 
MRI表现:蝶窦、斜坡、右侧额颞部颅板下可见团块状长T1、混杂T2信号(图1、2),脂肪抑制序列见混杂高信号,DWI高b值可见扩散受限高信号,边缘清晰(图3)。右侧额颞叶局部脑实质明显受压。右侧颞骨区可见斑片状、团块状长T1、长T2信号,向下方达颧骨上端内缘,累及右侧颞肌;右侧海绵窦受包绕,病变向前方筛窦内突入。增强扫描,蝶窦、斜坡、右侧额颞部颅板下、右侧颞骨、右侧颧骨内可见团块状异常强化信号。右侧颞部硬膜可见增厚强化(图4、5)。MRI诊断意见:蝶窦、斜坡、右侧额颞部颅板下、右侧颞骨及右侧颞肌走行区较大占位性病变,考虑恶性病变可能性大,右侧额颞部硬膜增厚强化,受累不除外,建议临床及病理协诊。
 


图1、2蝶窦、斜坡、右侧额颞部颅板下可见团块状长T1混杂长T2信号;右侧额颞骨区可见斑片状、团块状长T1、长T2信号,累及右侧颞肌;图3DWI可见扩散受限高信号,边缘清晰;图4、5增强扫描可见蝶窦、斜坡、右侧额颞部颅板下团块状异常强化;右侧额颞部硬膜可见增厚强化
 
手术及病理所见:开放蝶窦后见一隆起白色组织,质脆,表面尚光滑,有波动感,触之易出血,钳取少量组织送病理。肉眼所见:灰白、灰红组织一堆,大小共1.5 cm×1.0 cm×1.0 cm。病理诊断:非典型脑膜瘤,WHOⅡ级(图6)。免疫组织化学:CK(-),EMA(+),PR(+),GFAP(-),S-100(-),CD34(-),Ki-67(5%+),Vimentin(+)。

图6 病理诊断为非典型脑膜瘤,WHOⅡ级(HE×200)
 
讨论
 
脑膜瘤来源于软脑膜、硬脑膜及蛛网膜,约占颅内肿瘤的15%~30%,仅次于胶质瘤,居颅内肿瘤的第2位。可发生于颅内任何部位,幕上较幕下多见,好发部位有大脑凸面、矢状窦旁、大脑镰旁和颅底等,罕见于颅外,如眶内、鼻窦内或颅骨内。起源于硬膜外的脑膜瘤称为颅外脑膜瘤或异位脑膜瘤,约占全部脑膜瘤的1%~2%。而起源于颅内正常脑膜覆盖部位并沿邻近间隙、解剖腔(孔)向邻近部位蔓延的脑膜瘤,临床上称为颅内外沟通性脑膜瘤。由于该肿瘤较为罕见,且临床症状和体征无特异性,故极易误诊。
 
该患者右侧额颞部颅板下及右侧蝶窦内都证实为脑膜瘤,结合影像表现,考虑为右侧额颞部向蝶窦内蔓延的沟通性脑膜瘤。颅内外沟通性脑膜瘤因其发病率低,目前尚无大宗病例报道。沟通性脑膜瘤引起的临床症状主要与肿瘤的起源、部位、大小和累及的范围有关。因肿瘤可对周围结构的功能产生影响,症状往往表现出多样性。该患者表现为双眼肿胀,右侧颌面部麻木,临床表现不典型,影像学表现也与典型的脑膜瘤不同,极易误诊为鞍区及鞍旁其他肿瘤,应与垂体瘤、鞍区生殖细胞瘤、颅咽管瘤、鞍旁海绵状血管瘤相鉴别。
 
原始出处:

罗乐凯,任翠萍,张勇.蝶窦及颅内硬膜下沟通性脑膜瘤一例[J].临床放射学杂志,2018,37(02):208-209.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2041230, encodeId=db8c2041230d0, content=<a href='/topic/show?id=222c64498ba' target=_blank style='color:#2F92EE;'>#沟通性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64498, encryptionId=222c64498ba, topicName=沟通性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 09 01:07:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054158, encodeId=2eda2054158af, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Jul 09 03:07:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280838, encodeId=e71f128083802, content=<a href='/topic/show?id=a55385062c7' target=_blank style='color:#2F92EE;'>#脑膜瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85062, encryptionId=a55385062c7, topicName=脑膜瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 17 12:07:00 CST 2018, time=2018-11-17, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2041230, encodeId=db8c2041230d0, content=<a href='/topic/show?id=222c64498ba' target=_blank style='color:#2F92EE;'>#沟通性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64498, encryptionId=222c64498ba, topicName=沟通性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 09 01:07:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054158, encodeId=2eda2054158af, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Jul 09 03:07:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280838, encodeId=e71f128083802, content=<a href='/topic/show?id=a55385062c7' target=_blank style='color:#2F92EE;'>#脑膜瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85062, encryptionId=a55385062c7, topicName=脑膜瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 17 12:07:00 CST 2018, time=2018-11-17, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2041230, encodeId=db8c2041230d0, content=<a href='/topic/show?id=222c64498ba' target=_blank style='color:#2F92EE;'>#沟通性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64498, encryptionId=222c64498ba, topicName=沟通性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Jan 09 01:07:00 CST 2019, time=2019-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2054158, encodeId=2eda2054158af, content=<a href='/topic/show?id=39e8e362693' target=_blank style='color:#2F92EE;'>#硬膜下#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73626, encryptionId=39e8e362693, topicName=硬膜下)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6142500060, createdName=12498710m11暂无昵称, createdTime=Tue Jul 09 03:07:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280838, encodeId=e71f128083802, content=<a href='/topic/show?id=a55385062c7' target=_blank style='color:#2F92EE;'>#脑膜瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85062, encryptionId=a55385062c7, topicName=脑膜瘤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0a1165, createdName=jiangfeng5067, createdTime=Sat Nov 17 12:07:00 CST 2018, time=2018-11-17, status=1, ipAttribution=)]